aTyr Pharma of San Diego and Hong Kong Completes $49 Million Venture Round

05:50 EDT 30 Jul 2013 | ChinaBio Today

aTyr Pharma, a San Diego startup with a laboratory in Hong Kong, completed a $49 million financing. The company is developing a novel class of protein drugs for rare immune disorders. aTyr has a subsidiary in Hong Kong named Pangu BioPharma, which ca...

Original Article: aTyr Pharma of San Diego and Hong Kong Completes $49 Million Venture Round

NEXT ARTICLE

More From BioPortfolio on "aTyr Pharma of San Diego and Hong Kong Completes $49 Million Venture Round"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story